Industry Report on Early Phase Development
Integrated CPU And Bioanalytical Services Deliver Reduced Cycle Time And Cost Savings For Early Phase Trial Sponsors
In clinical trials where timeline and budget are critical concerns, sponsors need strategies to reduce time lag and increase efficiencies. A new industry report released by Worldwide Clinical Trials, “Integrated CPU and Bioanalytical Services Deliver Reduced Cycle Time and Cost Savings for Early Phase Trial Sponsors,” discusses the advantages sponsors receive when using our colocated clinical pharmacology unit (CPU) and bioanalytical (BioA) lab. In the report, we outline the benefits and suggest potential use cases where these benefits might best be realized.